Glycopyrronium

Last Updated: 02/24/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1505 publications

AQbD-driven UHPLC method for simultaneous quantification of budesonide, glycopyrronium bromide, and salbutamol sulphate: a unified approach for inhalation product and bioanalytical applications.

AQbD-driven UHPLC method for simultaneous quantification of budesonide, glycopyrronium bromide, and salbutamol sulphate: a unified approach for inhalation product and bioanalytical applications.

Journal: The Analyst
Published: December 15, 2025

Cost-effectiveness modeling of mortality risk reduction comparing two fixed-dose combination triple therapies in moderate-to-very severe chronic obstructive pulmonary disease.

Cost-effectiveness modeling of mortality risk reduction comparing two fixed-dose combination triple therapies in moderate-to-very severe chronic obstructive pulmonary disease.

Journal: Journal of comparative effectiveness research
Published: December 15, 2025

Death rattle : what is the appropriate management ?

Death rattle : what is the appropriate management ?

Journal: Revue medicale suisse
Published: December 11, 2025

Using Nebulised Glycopyrronium Bromide for Refractory Terminal Secretions in an Inpatient Hospice.

Using Nebulised Glycopyrronium Bromide for Refractory Terminal Secretions in an Inpatient Hospice.

Journal: Journal of pain and symptom management
Published: December 01, 2025

Reverse Takotsubo Cardiomyopathy After Treatment of Asymptomatic Bradycardia Prior to Anesthesia Induction in a Young Woman Undergoing Elective Rhinoplasty: A Case Report.

Reverse Takotsubo Cardiomyopathy After Treatment of Asymptomatic Bradycardia Prior to Anesthesia Induction in a Young Woman Undergoing Elective Rhinoplasty: A Case Report.

Journal: The American journal of case reports
Published: November 14, 2025

Comparison of the effect of preoperative glycopyrrolate and penehyclidine hydrochloride on postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: A randomized controlled trial.

Comparison of the effect of preoperative glycopyrrolate and penehyclidine hydrochloride on postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: A randomized controlled trial.

Journal: The Journal of international medical research
Published: November 01, 2025

From controlled trials to real-world evidence: Learning from the glycopyrronium treatment journey.

From controlled trials to real-world evidence: Learning from the glycopyrronium treatment journey.

Journal: European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
Published: October 31, 2025

Effectiveness and Safety of Glycopyrronium-Formoterol-Budesonide Triple Therapy in Chronic Obstructive Pulmonary Disease (AIR-FORCE): An Open-Label Multi-Centric Phase 4 Study.

Effectiveness and Safety of Glycopyrronium-Formoterol-Budesonide Triple Therapy in Chronic Obstructive Pulmonary Disease (AIR-FORCE): An Open-Label Multi-Centric Phase 4 Study.

Journal: Advances in respiratory medicine
Published: September 16, 2025

TiO2-embedded molecularly imprinted polymer as electrochemical sensor for ultrasensitive determination of glycopyrronium bromide.

TiO2-embedded molecularly imprinted polymer as electrochemical sensor for ultrasensitive determination of glycopyrronium bromide.

Journal: ADMET & DMPK
Published: September 13, 2025

Real-World Efficacy of Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrronium on Diaphragmatic Workload Assessed by Ultrasound and Lung Function in Patients with Uncontrolled Asthma.

Real-World Efficacy of Beclomethasone Dipropionate/Formoterol Fumarate/Glycopyrronium on Diaphragmatic Workload Assessed by Ultrasound and Lung Function in Patients with Uncontrolled Asthma.

Journal: Advances in respiratory medicine
Published: August 29, 2025

TETRIS - Prospective study to observe clinical outcomes of triple therapy in COPD patients: Up to 12 months interim analysis.

TETRIS - Prospective study to observe clinical outcomes of triple therapy in COPD patients: Up to 12 months interim analysis.

Journal: Respiratory medicine
Published: August 19, 2025

Real-World Outcomes in Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dehydrate in Spain: ORESTES Study.

Real-World Outcomes in Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dehydrate in Spain: ORESTES Study.

Journal: Advances in therapy
Published: August 06, 2025
Showing 1-12 of 1,505

Last Updated: 02/24/2026